BioCentury
ARTICLE | Company News

BRIM Biotechnology, J&J deal

July 13, 2015 7:00 AM UTC

Johnson & Johnson’s Janssen Pharmaceutica N.V. unit partnered with BRIM to develop and commercialize undisclosed preclinical compounds identified by J&J for dengue disease. The companies will move the...